| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.29 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |